Willebrand


Also found in: Thesaurus, Medical, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Willebrand - Finnish physician who first described vascular hemophilia (1870-1949)Willebrand - Finnish physician who first described vascular hemophilia (1870-1949)
References in periodicals archive ?
Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD).
Since its first donation in 2009, CSL Behring has provided nearly 14 million IUs of its bleeding disorder protein therapies to treat people with hemophilia or von Willebrand disease (VWD) in developing countries.
An EIA for the quantification of human von Willebrand factor antigen in plasma.
MONTREAL, June 25, 2013 /PRNewswire/ -- For 50 years, the World Federation of Hemophilia (WFH) has provided global leadership to improve and sustain care for people with inherited bleeding disorders, including hemophilia, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders.
The function of von Willebrand factor (VWF) [5] is dependent on the presence of high molecular weight multimers (HMWM).
The characterization of Heyde syndrome now refers to the triad of AS, acquired coagulopathy (von Willebrand syndrome type 2A, or vWS-2A) and anemia due to bleeding from intestinal angiodysplasia.
Since starting its “Education is Power” scholarship program in 2006, MedPro Rx has distributed more than $340,000 to students nationwide who have either hemophilia or von Willebrand Disease (vWD).
The biomarkers measured included those associated with systemic inflammation (fibrinogen, C-reactive protein [CRP], white blood cell [WBC] count) and thrombosis or endothelial dysfunction (platelet activation markers P-selectin [sCD62P] and soluble CD40 ligand [sCD40L] as well as the adhesive endothelial glycoprotein von Willebrand factor).
Von Willebrand disease; basic and clinical aspects.
Most clinicians do not have onsite access to the level of expertise required to manage hemophilia A and B, Von Willebrand disease, factor deficiencies, and rare platelet and coagulation disorders such as acquired bleeding diastheses, and thrombotic disorders.